# Celldex Therapeutics, Inc.: Form DEF 14A, filed Apr 27, 2021

- Company: [Celldex Therapeutics, Inc.](/companies/cldx.md) (CIK 744218)
- Form: DEF 14A
- Filed: 2021-04-27
- Accepted by EDGAR: Apr 27, 2021, 16:06 ET
- Period: 2021-06-17
- Accession: 0001104659-21-055589
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/744218/000110465921055589/tm212386-1_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/744218/000110465921055589/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/744218/000110465921055589/tm212386-1_def14a.htm

Filed Apr 27, 2021.
Source: SEC EDGAR, the filing index for accession 0001104659-21-055589. Last ingested by Listed: Nov 5, 2026, 19:04 ET. No prices; not investment advice.
